Literature DB >> 27475248

Urinary KIM-1, but not urinary cystatin C, should be corrected for urinary creatinine.

Johanna Helmersson-Karlqvist1, Johan Ärnlöv2, Axel C Carlsson3, Lars Lind4, Anders Larsson4.   

Abstract

OBJECTIVES: The interest for tubular damage markers such as urinary cystatin C (U-CystC) and kidney injury molecule-1 (U-KIM-1) grows, especially for the diagnosis of acute kidney injury. The trend to measure proteins in spot urine samples instead of 24-h urine collections calls for adjustment of urine dilution with urinary creatinine (UCr). However, it is not known whether UCr adjustment provides a more true value of basal U-CystC and U-KIM-1 levels than absolute values. DESIGN &
METHODS: This study examines the rationale for UCr correction for U-CystC and U-KIM-1 by exploring the linear relations between U-CystC and U-KIM-1 and UCr, respectively, and the biological day to day variation of absolute concentrations and UCr adjusted values of the two biomarkers.
RESULTS: Both U-CystC and U-KIM-1 concentrations correlated positively with UCr (R=0.37, P<0.001 and R=0.62, P<0.001, respectively) in 378 participants in a community cohort, which indicated a rationale for adjustment with UCr. However, U-CystC/Cr ratio associated negatively with UCr (R=- 0.31, P<0.001), which could indicate a certain amount of 'over-adjustment'. Morning urine collected for 10 consecutive days from 13 healthy volunteers showed a biological day to day variation of 82% for U-CystC, 75% for U-cystC/Cr ratio, 70% for U-KIM-1 and 46% for U-KIM-1/Cr ratio.
CONCLUSIONS: This study supports the use of U-KIM-1/Cr ratio in clinical population studies. Data supporting the use of U-CysC/U-Cr ratio were less convincing and the possible confounding of UCr has to be acknowledged in clinical settings.
Copyright © 2016 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biological variation; Creatinine ratio; Cystatin C; Kidney injury molecule-1; Tubular biomarker

Mesh:

Substances:

Year:  2016        PMID: 27475248     DOI: 10.1016/j.clinbiochem.2016.07.015

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

1.  Urinary Cystatin-C, a marker to assess and monitor neonatal kidney maturation and function: validation in twins.

Authors:  Antonella Barbati; Maria Cristina Aisa; Benito Cappuccini; Mariarosalba Zamarra; Sandro Gerli; Gian Carlo Di Renzo
Journal:  Pediatr Res       Date:  2020-05-18       Impact factor: 3.756

2.  Day-to-day variation of the kidney proximal tubular injury markers urinary cystatin C, KIM1, and NGAL in patients with chronic kidney disease.

Authors:  Inga Soveri; Johanna Helmersson-Karlqvist; Bengt Fellström; Anders Larsson
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

3.  High Serum Uric Acid Is Associated with Tubular Damage and Kidney Inflammation in Patients with Type 2 Diabetes.

Authors:  Naiara S Guarda; Yãnaí S Bollick; José Antonio M de Carvalho; Melissa O Premaor; Fabio V Comim; Rafael N Moresco
Journal:  Dis Markers       Date:  2019-04-11       Impact factor: 3.434

4.  Interference with megalin expression/endocytic function by montelukast mitigates gentamicin nephrotoxicity: Downregulation of ClC-5 expression.

Authors:  Amany A Azouz; Dina A Hanna; Ali A Abo-Saif; Basim Anwar Shehata Messiha
Journal:  Saudi Pharm J       Date:  2022-01-04       Impact factor: 4.562

5.  Serum Adipocyte Fatty Acid-Binding Protein 4 Levels Are Independently Associated with Radioisotope Glomerular Filtration Rate in Type 2 Diabetic Patients with Early Diabetic Nephropathy.

Authors:  Xiaoqing Ni; Yunjuan Gu; Haoyong Yu; Shenqi Wang; Ying Chen; Xinlei Wang; Xinlu Yuan; Weiping Jia
Journal:  Biomed Res Int       Date:  2018-05-27       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.